Evaluation of fecal immunochemical tests for colorectal cancer screening

Journal of Primary Care and Community Health

Volumn 4, Issue 4, 2013, Pages 245-250

  Daly, Jeanette M ^a   Bay, Camden P ^a   Levy, Barcey T ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Colorectal cancer screening; Fecal immunochemical test (FIT); Fecal occult blood test (FOBT); Proficiency testing programs

Indexed keywords

HEMOGLOBIN;

ARTICLE; CHEMISTRY; COLORECTAL CANCER SCREENING; COLORECTAL TUMOR; EARLY DIAGNOSIS; EVALUATION STUDY; FECAL IMMUNOCHEMICAL TEST (FIT); FECAL OCCULT BLOOD TEST (FOBT); FECES; HUMAN; IMMUNOCHEMISTRY; MASS SCREENING; METHODOLOGY; OCCULT BLOOD; PROFICIENCY TESTING PROGRAMS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

COLORECTAL CANCER SCREENING; FECAL IMMUNOCHEMICAL TEST (FIT); FECAL OCCULT BLOOD TEST (FOBT); PROFICIENCY TESTING PROGRAMS;

COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FECES; HEMOGLOBINS; HUMANS; IMMUNOCHEMISTRY; MASS SCREENING; OCCULT BLOOD; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84905523239     PISSN: 21501319     EISSN: 21501327     Source Type: Journal    
DOI: 10.1177/2150131913487561     Document Type: Article

References (27)

1. Centers for Disease Control and Prevention. Colorectal cancer. CDC Vital Signs. http://www.cdc.gov/VitalSigns/ CancerScreening/
2. Levin TR, Jamieson L, Burley DA, Reyes J, Oehrli M, Caldwell C. Organized colorectal cancer screening in integrated health care systems. Epidemiol Rev. 2011;33: 101-110.
3. Center MM, Jemal A, Smith RA, Ward E. Worldwide variations in colorectal cancer. CA Cancer J Clin. 2009;59: 366-378.
4. Potter MB, Walsh JM, Yu TM, Gildengorin G, Green LW, McPhee SJ. The effectiveness of the FLU-FOBT program in primary care a randomized trial. Am J Prev Med. 2011;41: 9-16.
5. Potter MB, Phengrasamy L, Hudes ES, McPhee SJ, Walsh JM. Offering annual fecal occult blood tests at annual flu shot clinics increases colorectal cancer screening rates. Ann Fam Med. 2009;7:17-23.
6. Levy BT, Daly JM, Luxon B, et al. The "Iowa Get Screened" colon cancer screening program. J Prim Care Community Health. 2010;1:43-49.
7. American Cancer Society. Colorectal cancer facts & figures 2011-2013. http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/ documents/document/acspc-028323. pdf. Updated 2011. Accessed September 28, 2011.
8. Cheng TI, Wong JM, Hong CF, et al. Colorectal cancer screening in asymptomatic adults: comparison of colonoscopy, sigmoidoscopy and fecal occult blood tests. J Formos Med Assoc. 2002;101:685-690.
9. Nakama H, Kamijo N, Abdul Fattah AS, Zhang B. Validity of immunological faecal occult blood screening for colorectal cancer: a follow up study. J Med Screen. 1996;3:63-65.
10. Nakama H, Yamamoto M, Kamijo N, et al. Colonoscopic evaluation of immunochemical fecal occult blood test for detection of colorectal neoplasia. Hepatogastroenterology. 1999;46:228-231.
11. Rozen P, Waked A, Vilkin A, Levi Z, Niv Y. Evaluation of a desk top instrument for the automated development and immunochemical quantification of fecal occult blood. Med Sci Monit. 2006;12:MT27-MT32.
12. Park DI, Ryu S, Kim YH, et al. Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening. Am J Gastroenterol. 2010;105:2017-2025.
13. Zhu MM, Xu XT, Nie F, Tong JL, Xiao SD, Ran ZH. Comparison of immunochemical and guaiac-based fecal occult blood test in screening and surveillance for advanced colorectal neoplasms: a meta-analysis. J Dig Dis. 2010;11:148-160.
14. Gimeno-García AZ, Quintero E, Nicolás-Pérez D, Hernández-Guerra M, Parra-Blanco A, Jiménez-Sosa A. Screening for familial colorectal cancer with a sensitive immunochemical fecal occult blood test: a pilot study. Eur J Gastroenterol Hepatol. 2009;21:1062-1067.
15. Launoy GD, Bertrand HJ, Berchi C, et al. Evaluation of an immunochemical fecal occult blood test with automated reading in screening for colorectal cancer in a general average-risk population. Int J Cancer. 2005;115:493-496.
16. Levi Z, Rozen P, Hazazi R, et al. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med. 2007;146:244-255.
17. Itoh M, Takahashi K, Nishida H, Sakagami K, Okubo T. Estimation of the optimal cut off point in a new immunological faecal occult blood test in a corporate colorectal cancer screening programme. J Med Screen. 1996;3:66-71.
18. Allison JE, Sakoda LC, Levin TR, et al. Screening for colorectal neoplasms with new fecal occult blood tests: Update on performance characteristics. J Natl Cancer Inst. 2007;99:1462-1470.
19. Allen TC, Hammond ME, Robboy SJ. Quality and the College of American Pathologists. Arch Pathol Lab Med. 2011;135:1441.
20. Agresti A, Coull BA. Approximate is better than "exact" for interval estimation of binomial proportions. Am Stat. 1998;52:119-126.
21. van Rossum LG, van Rijn AF, van Oijen MG, et al. False negative fecal occult blood tests due to delayed sample return in colorectal cancer screening. Int J Cancer. 2009;125:746-750.
22. Vilkin A, Rozen P, Levi Z, et al. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test. Am J Gastroenterol. 2005;100:2519-2525.
23. Terhaarsive Droste JS, Oort FA, van der Hulst RW, et al. Higher fecal immunochemical test cutoff levels: lower positivity rates but still acceptable detection rates for early-stage colorectal cancers. Cancer Epidemiol Biomarkers Prev. 2011;20:272-280.
24. Young GP, St. John DJB. Faecal occult blood tests: choice, usage and clinical applications. Clin Biochem Rev. 1992;13:161-167.
25. Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology. 2003;124: 544-560.
26. US Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149:627-637.
27. Winawer SJ, Krabshuis J, Lambert R, O'Brien M, Fried, M, World Gastroenterology Organization Guidelines Committee. Cascade colorectal cancer screening guidelines: a global conceptual model. J Clin Gastroenterol. 2011;45: 297-300.